Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Allopurinol

A xanthine oxidase inhibitor that reduces the production of uric acid, developed in the United States by Gertrude Elion and George Hitchings and used against gout since the mid-1960s. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.

Did you know?It was first studied for another purpose: protecting the anti-leukaemia drug 6-mercaptopurine from being broken down. Elion and Hitchings later received the 1988 Nobel Prize in Medicine.

AllopurinolGo to the active ingredient →
AllopurinolActive ingredientAllopurinolCat. No. P-A082-001CAS 315-30-0
Allopurinol-d2Isotopically labelledAllopurinol-d2Cat. No. P-A082-010CAS 916979-34-5
OxypurinolImpurityOxypurinolCat. No. P-A082-019CAS 2465-59-0

EDQM standards 5

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.